Henry ScheinHSIC +1.22%80 Buyback Yield % is 8.45 as of Jul. 02, 2026, which is 114% above its 10-year median of 3.95. GuruFocus rates HSIC with a GF Score™ of 80/100 and a GF Value™ of $83.72 (Fairly Valued). The stock has 8 warning signs investors should review. Among 40 Medical Distribution companies, Henry Schein ranks better than 92.5% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Henry Schein's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HSIC vs AHG, ACH, FOCL: Buyback Yield % Comparison
For the Medical Distribution subindustry, Henry Schein's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Henry Schein's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henry Schein (HSIC) has a Buyback Yield % of 8.45 as of Jul. 02, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Henry Schein and its competitors. This is 114% above median its historical median of 3.95. According to the industry distribution chart, Henry Schein ranks #3 out of 40 companies in the Medical Distribution industry, placing it in the top 7.5%.
Is Henry Schein's Buyback Yield % too high?
Henry Schein's current Buyback Yield % of 8.45 is 114% above median its 10-year median of 3.95. The Medical Distribution industry median Buyback Yield % is 0.02. Henry Schein's value of 8.45 is 42150% above this industry median. Based on the distribution chart, Henry Schein ranks #3 out of 40 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Henry Schein has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's Buyback Yield % compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #3 out of 40 companies for Buyback Yield %. This places Henry Schein in the top 8% of its industry — outperforming the majority of peers. The industry median Buyback Yield % is 0.02. Henry Schein's value of 8.45 is 42150% above this benchmark. While the company's 10-year median is 3.95 vs. the industry median of 0.02, Henry Schein has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.02, based on 40 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henry Schein's current Buyback Yield % of 8.45 is 42150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Henry Schein and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current Buyback Yield % is 8.45, which is 114% above median its own 10-year median of 3.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $83.72, compared to a current price of $84.52 — trading 0.9% above its estimated fair value. The current Buyback Yield % is 8.45, which is 114% above median its 10-year median of 3.95 and 42150% above the Medical Distribution industry median of 0.02. Henry Schein's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Henry Schein (HSIC), the current Buyback Yield % is 8.45 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of $84.52 is trading 0.9% above its estimated GF Value™ of $83.72.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for HSIC:
Buyback Yield %: 8.45 (114% above median its 10-year median of 3.95)
GF Value™: $83.72 vs. price of $84.52 (0.9% above fair value)
Industry Position: 42150% above the Medical Distribution median (#3 of 40)
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
80GF Score
Get the complete analysis for HSIC
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 
